IP Library Assignment 020542/0441
Patent Assignment
Reel/Frame 020542/0441

Corrective Assignment to Correct the Address of the Assignee Previously Recorded on Reel 020091 Frame 0039. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest..

Recorded: 2008-02-21 Pages: 6
Assignors
ADELMAN, DANIEL C.
Executed: 2007-10-19
SILVERMAN, JEFFREY A.
Executed: 2007-10-19
MICHELSON, GLEN
Executed: 2007-10-19
SCATENA, CAROLINE DARNE
Executed: 2007-10-19
Assignee
SUNESIS PHARMACEUTICALS, INC.
341 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO,, CALIFORNIA, 94080
Covered Property (1)
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
Application: 11/890,196 →
Publication: US 2008/0063642
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 9, 2007
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.; MICHELSON, GLENN; SCATENA, CAROLINE DARNE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 020091/0039 →
Security Agreement May 7, 2012
From: SUNESIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 028169/0528 →
Release of Security Interest Apr 1, 2016
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 038330/0382 →
Security Interest May 10, 2016
From: SUNESIS PHARMACEUTICALS, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 038655/0493 →
Release of Security Interest Nov 5, 2020
From: WESTERN ALLIANCE BANK
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 054335/0429 →